Market Cap (In CHF)
2.01 Billion
Revenue (In CHF)
-199.56 Million
Net Income (In CHF)
-206.6 Million
Avg. Volume
57.75 Thousand
- Currency
- CHF
- Country
- Healthcare
- Open
- -
- Prev. Close
- -
- Day Range
- -
- Year Range
- 35.4-49.8
- PE
- -
- EPS
- -
- Beta Value
- 0.826
- ISIN
- CH0038389992
- CUSIP
- -
- CIK
- -
- Shares
- -
- Earnings Annoncement
- -
Company Profile
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Employee Count
- -
- Website
- https://www.bbbiotech.ch/en/bb-biotech/
- Ipo Date
- 2000-01-04
- Details
- BB Biotech AG is an equity fund launched and managed by Bellevue Asset Management AG. The fund invests in the public equity markets across the globe. It primarily invests in stocks of companies that are engaged in medications and diagnostics based on modern biotechnology. The fund employs a fundamental analysis to create its portfolio. BB Biotech AG was formed on November 09, 1993 and is domiciled in Switzerland.
More Stocks
-
GTHP
-
NLY-PF
-
GOGL
-
028300HLB Co., Ltd.
028300
-
688588Linkage Software Co., LTD
688588
-
002862
-
KALAMANDIRSai Silks (Kalamandir) Limited
KALAMANDIR
-
004370Nongshim Co., Ltd.
004370